Immune Thrombocytopenia (ITP) Immune-Genetic Assessment (UNIT)

March 19, 2018 updated by: Azienda Sanitaria-Universitaria Integrata di Udine

IMMUNE-GENETIC ASSESSMENT OF PRIMARY ITP IN ADULT

Primary ITP has wide heterogenous biology, presentation and response to therapy.

The immune-genetic assessment of ITP may help to identify differences among patients with ITP and optimize the therapeutic choice.

Study Overview

Status

Unknown

Conditions

Study Type

Observational

Enrollment (Anticipated)

190

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Italy
      • Bologna, Italy, 40100
        • Recruiting
        • Istituto di Ematologia L. & A. Seragnoli
        • Contact:
          • Nicola Vianelli, MD
      • Cagliari, Italy, 09100
        • Not yet recruiting
        • Department of Hematology and Bone Marrow Transplantation Unit, Oncology Center Armando Businco
        • Contact:
          • Emilio Usala, MD
      • Firenze, Italy
        • Not yet recruiting
        • UF Ematologia, Policlinico di Careggi
        • Contact:
          • Antonella Gozzini, MD
      • Milano, Italy, 20122
        • Not yet recruiting
        • U.O. Ematologia 2, IRCCS Cà Granda Ospedale Maggiore Policlinico
        • Contact:
          • Wilma Barcellini, MD
      • Milano, Italy
        • Recruiting
        • Department of Oncology/Haematology, Niguarda Ca'Granda Hospital
        • Contact:
          • Silvia Cantoni, MD
      • Novara, Italy, 28100
        • Recruiting
        • Clinica Ematologica, Dipartimento di Medicina Clinica e Sperimentale, Università degli Studi del Piemonte Orientale "Amedeo Avogadro
        • Contact:
          • Gianluca Gaidano, Prof.
      • Novara, Italy, 28100
        • Active, not recruiting
        • Istituto di Immunologia, Dipartimento di Scienze Mediche dell'Università degli Studi del Piemonte Orientale "Amedeo Avogadro"
      • Padova, Italy, 35100
        • Not yet recruiting
        • Department of Medical and Surgical Sciences, University of Padova
        • Contact:
          • Fabrizio Fabris, Prof.
      • Ravenna, Italy, 48121
        • Not yet recruiting
        • Oncology-Hematology Department, "S. Maria delle Croci" Hospital
        • Contact:
          • Alfonso Zaccaria, MD
      • Roma, Italy, 00168
        • Not yet recruiting
        • Institute of Hematology, Catholic University,
      • Treviso, Italy, 31100
        • Not yet recruiting
        • Ematologia, Ospedale Ca' Foncello
      • Udine, Italy, 33100
      • Vicenza, Italy, 36100
        • Not yet recruiting
        • Ematologia, San Bortolo Hospital
        • Contact:
          • Francesco Rodeghiero, Prof.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Primary care clinic

Description

Inclusion Criteria:

  • Adult patients with primary ITP

Exclusion Criteria:

  • Secondary ITP

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Asymptomatic ITP patients
ITP patients treated with Rituximab
ITP patients treated with steroids

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Azienda Sanitaria-Universitaria Integrata di Udine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2010

Study Registration Dates

First Submitted

September 7, 2010

First Submitted That Met QC Criteria

September 8, 2010

First Posted (Estimate)

September 9, 2010

Study Record Updates

Last Update Posted (Actual)

March 20, 2018

Last Update Submitted That Met QC Criteria

March 19, 2018

Last Verified

September 1, 2010

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • UNIT

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Thrombocytopenia

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe